Hermetica Superfood Encyclopedia
The Short Answer
Hypoxoside is a phenylheptenyl glucoside extracted primarily from the African potato (Hypoxis hemerocallidea), where it acts as a biologically inactive prodrug converted in vivo to the active aglycone rooperol via beta-glucosidase activity. Rooperol then exerts antioxidant, antimutagenic, and selective cytotoxic effects through catechol-mediated free radical scavenging and interference with cellular proliferation pathways.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordhypoxoside benefits
Synergy Pairings3
Hypoxoside — botanical close-up
Health Benefits
Origin & History
Natural habitat
Hypoxoside is a pentenyne glycoside isolated from the African potato plant (Hypoxis hemerocallidea), native to southern Africa. It is extracted from plant materials using chromatography on Sephadex LH-20 with methanol-water (1:1) and contains two glucose units attached to benzene rings in a pentenyne skeleton.
“Hypoxis hemerocallidea (African potato) has been used in southern African traditional medicine, though specific historical applications of hypoxoside are not documented. The plant is recognized in chemical-historical reviews of African medicinal plants.”Traditional Medicine
Scientific Research
No human clinical trials, RCTs, or meta-analyses for hypoxoside were found in the research. Current evidence is limited to in vitro studies showing antimicrobial and anticancer properties when used in silver nanoparticle synthesis.
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges are available as human trials are absent. Hypoxoside content in Hypoxis hemerocallidea reaches up to 4.5%. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Hypoxoside is a norlignan diglucoside (chemical formula C₃₀H₃₈O₁₄, molecular weight ~626.6 g/mol) and is not a nutrient per se but rather a bioactive phytochemical primarily found in the corm of Hypoxis hemerocallidea (African potato). It is classified as a rooperol diglucoside, meaning it consists of the aglycone rooperol (a catechol derivative) bound to two glucose molecules. Key bioactive characteristics: The parent compound hypoxoside itself is considered a prodrug; it is converted by β-glucosidase enzymes (present in the gastrointestinal tract and released by certain cells, including activated immune cells and some tumor cells) into its biologically active aglycone, rooperol (C₁₈H₁₈O₆, MW ~330.3 g/mol). Rooperol is a dicatechol with significant antioxidant capacity due to its multiple phenolic hydroxyl groups. Approximate concentration in source material: Hypoxoside constitutes approximately 3.5–4.5% (w/w) of dried Hypoxis hemerocallidea corm, with some reports citing up to 6% depending on harvest conditions, geographic origin, and extraction methods. Typical standardized extracts may contain 2.5–4% hypoxoside. Bioavailability notes: Oral bioavailability of hypoxoside is moderate; the intact diglucoside is absorbed from the gastrointestinal tract and can be detected in serum. Conversion to rooperol occurs both in the gut lumen (via microbial β-glucosidases) and at target tissues. Phase II metabolism of rooperol produces sulfate and glucuronide conjugates (rooperol di-sulfate, rooperol sulfate-glucuronide, rooperol di-glucuronide), which circulate in plasma and are renally excreted. In clinical pharmacokinetic studies (oral doses of 1,200–3,200 mg crude extract), peak plasma levels of hypoxoside and rooperol metabolites were reached within 2–4 hours. The aglycone rooperol has higher biological activity than the parent glycoside but also higher susceptibility to first-pass metabolism. No significant macronutrient content (protein, fat, carbohydrate, fiber) is attributed to hypoxoside as an isolated compound. It contains no vitamins or minerals. Co-occurring compounds in Hypoxis corm extracts include other norlignan glycosides (dehydroxyhypoxoside, bis-dehydroxyhypoxoside), phytosterols (notably β-sitosterol and stigmasterol), stanols, and trace minerals from the plant matrix, but these are distinct from hypoxoside itself.
How It Works
Mechanism of Action
Hypoxoside is hydrolyzed by intestinal or microbial beta-glucosidase enzymes into rooperol, a dihydroxyphenylheptenol catechol compound that functions as the pharmacologically active moiety. Rooperol scavenges reactive oxygen species via its catechol hydroxyl groups and has been observed to inhibit lipoxygenase and cyclooxygenase pathways, reducing pro-inflammatory eicosanoid synthesis. In glioblastoma cell lines U87 and U251, rooperol appears to selectively induce cytotoxicity, potentially through interference with tubulin polymerization and disruption of mitotic spindle assembly, though the precise receptor targets remain under investigation.
Clinical Evidence
The evidence base for hypoxoside is limited almost entirely to in vitro and animal studies, with no large-scale randomized controlled trials in humans published to date. In vitro assays demonstrated antimicrobial activity against gram-negative pathogens including Escherichia coli and Salmonella enterica, and antimutagenic effects in Ames test models, though these findings have not been validated in human clinical settings. Selective cytotoxicity against glioblastoma cell lines U87 and U251 was observed at specific rooperol concentrations in cell culture, representing preliminary proof-of-concept data only. Toxicological screening in animal models suggests a low acute toxicity profile, but human pharmacokinetic and efficacy data are currently insufficient to support therapeutic dosing recommendations.
Safety & Interactions
Hypoxoside from African potato (Hypoxis hemerocallidea) preparations has raised safety concerns in HIV-positive populations, where widespread traditional use in South Africa has been associated in some reports with potential interference with antiretroviral drug metabolism, possibly through modulation of CYP3A4 and P-glycoprotein activity by rooperol. High-dose African potato extracts have been linked in case reports to pancytopenia, though it is unclear whether hypoxoside specifically or other phytoconstituents are responsible. Use during pregnancy and lactation is not recommended due to the complete absence of safety data in these populations. Individuals on immunosuppressive medications, chemotherapeutics, or anticoagulants should avoid hypoxoside supplementation until drug interaction studies are conducted.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
African potato glycosideHypoxis hemerocallidea glycosidepentenyne glycosideAfrican potato extract compoundHypoxis glycoside
Frequently Asked Questions
What is hypoxoside and where does it come from?
Hypoxoside is a phenylheptenyl glucoside found predominantly in the corm of Hypoxis hemerocallidea, commonly called the African potato, a plant native to sub-Saharan Africa used extensively in traditional Zulu and Sotho medicine. It exists as a stable, water-soluble glucoside in the plant and requires enzymatic conversion to its active aglycone, rooperol, to exert biological effects. Hypoxoside concentrations in the dried corm typically range from 0.3% to 1.5% by dry weight depending on growing conditions and harvest timing.
What does hypoxoside do in the body?
After ingestion, hypoxoside is converted by beta-glucosidase enzymes in the gut into rooperol, a catechol-containing compound that serves as the active metabolite. Rooperol then circulates systemically, where its dihydroxyphenyl groups donate electrons to neutralize reactive oxygen species and inhibit pro-inflammatory enzymes including lipoxygenase and cyclooxygenase. This conversion is dose- and microbiome-dependent, meaning bioavailability of active rooperol may vary considerably between individuals.
Is hypoxoside effective against cancer?
Current evidence is limited to in vitro cell culture studies showing that rooperol, the active metabolite of hypoxoside, selectively kills glioblastoma cell lines U87 and U251 at specific concentrations while showing lower toxicity to normal cells. No human clinical trials have been conducted to validate anticancer efficacy, and extrapolating in vitro cytotoxicity data to clinical outcomes is not scientifically justified. Patients with cancer should not use hypoxoside as a substitute for evidence-based oncology treatment.
Is it safe to take hypoxoside if I am HIV-positive?
This is a critical safety concern: African potato products containing hypoxoside are widely consumed in southern Africa by HIV-positive individuals as a traditional remedy, but South African health authorities and researchers have flagged potential interactions with antiretroviral therapy. Rooperol may modulate CYP3A4 enzyme activity and P-glycoprotein, potentially altering plasma concentrations of protease inhibitors and non-nucleoside reverse transcriptase inhibitors. The South African Medicines Control Council has issued advisories cautioning HIV-positive patients against self-medicating with African potato preparations until formal drug interaction studies are completed.
What is the difference between hypoxoside and rooperol?
Hypoxoside is the naturally occurring, biologically inactive glucoside prodrug found in Hypoxis hemerocallidea, while rooperol (chemically named 1,5-bis-(3,4-dihydroxyphenyl)-1E-penten-4-yne) is the pharmacologically active aglycone released after beta-glucosidase cleaves the glucose moiety from hypoxoside. Rooperol carries the catechol functional groups responsible for antioxidant, anti-inflammatory, and cytotoxic activities, whereas hypoxoside itself has minimal direct biological activity. This prodrug relationship means that the therapeutic effect of any hypoxoside supplement depends heavily on gut enzyme activity and individual microbiome composition.
What does the research evidence show about hypoxoside's effectiveness?
Current evidence for hypoxoside is limited to preliminary in vitro (laboratory) studies, which have shown promising antimicrobial activity against E. coli and S. enterica, as well as selective cytotoxicity to certain glioblastoma cell lines. However, these results have not yet been confirmed in human clinical trials, meaning efficacy in living organisms remains unproven. In vitro studies are an important first step in drug development but cannot be considered reliable indicators of real-world effectiveness. More rigorous human studies are needed before hypoxoside can be recommended for any specific health condition.
Who should consider taking hypoxoside supplements and who should avoid them?
Because hypoxoside has only preliminary in vitro evidence and no established clinical use in humans, there are currently no population groups for whom supplementation is clearly recommended. Individuals with specific health conditions—particularly those with cancer, immunocompromise, or those taking medications—should consult a healthcare provider before use, as potential interactions and safety concerns have not been adequately studied in human populations. Pregnant women, nursing mothers, and children should avoid hypoxoside until safety data in these populations becomes available. The lack of robust human safety data means individual risk assessment is essential before use.
How does hypoxoside's antioxidant activity work compared to its other properties?
Hypoxoside itself has preliminary evidence suggesting antioxidant potential, but much of this activity appears to be mediated through its metabolite rooperol, which the body produces after hypoxoside is consumed. This means hypoxoside's antioxidant benefits may depend on the body's ability to convert it effectively, which can vary between individuals based on metabolism and gut health. The antimicrobial and cytotoxic properties observed in laboratory studies appear to be distinct mechanisms from the antioxidant activity, suggesting hypoxoside may have multiple biological pathways. All of these effects remain unconfirmed in human subjects and require further investigation.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w hypoxoside curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
